Journal of Internal Medicine Concepts & Practice >

2024 , Vol. 19 >Issue 03: 207 - 211

DOI: https://doi.org/10.16138/j.1673-6087.2024.03.11

Review

Interaction of bile acids with the gut microbiota and their effects on sepsis

  • YANG Jin ,
  • WEI Yao ,
  • JIN Jun
Expand
  • Department of Critical Care Medicine, the First Affiliated Hospital of Soochow University, Suzhou 215006, China

Received date: 2023-12-25

  Online published: 2024-09-09

Fold

Abstract

Numerous microorganisms inhabit the human intestine, participate in the digestion and absorption of nutrients, and produce a large number of metabolites, participate in regulating functions and protect the host from disease damage. Bile acids are produced by cholesterol metabolism and metabolized by the gut microbiota into secondary bile acids. Bile acids facilitate lipid digestion and absorption and interact with the gut microbiota. The composition and quantity of the gut microbiota also regulate bile acid metabolism. As sepsis occurs, the poor prognosis of the disease is associated with disturbances of the gut microbiota and bile acid metabolism. This paper reviews the metabolic process of bile acids, the interaction between bile acids and the gut microbiota, and the changes of gut microbiota and bile acids during sepsis, to provide new ideas for the prevention and treatment of sepsis.

Key words： Bile acids; Gut microbiota; Sepsis; Metabolomics; Cytokine

Cite this article

YANG Jin , WEI Yao , JIN Jun . Interaction of bile acids with the gut microbiota and their effects on sepsis[J]. Journal of Internal Medicine Concepts & Practice, 2024 , 19(03) : 207 -211 . DOI: 10.16138/j.1673-6087.2024.03.11

References

[1] Lin S, Wang S, Wang P, et al. Bile acids and their receptors in regulation of gut health and diseases[J]. Prog Lipid Res, 2023, 89:101210.
[2] Eleftheriotis G, Tsounis EP, Aggeletopoulou I, et al. Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential[J]. Front Immunol, 2023, 14:1129190.
[3] Shi Q, Yuan X, Zeng Y, et al. Crosstalk between gut microbiota and bile acids in cholestatic liver disease[J]. Nutrients, 2023, 15(10):2411.
[4] Perino A, Demagny H, Velazquez-Villegas L, et al. Molecular physiology of bile acid signaling in health, disease, and aging[J]. Physiol Rev, 2021, 101(2):683-731.
[5] Cai J, Rimal B, Jiang C, et al. Bile acid metabolism and signaling, the microbiota, and metabolic disease[J]. Pharmacol Ther, 2022, 237:108238.
[6] Li-Hawkins J, G?fvels M, Olin M, et al. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice[J]. J Clin Invest, 2002, 110(8):1191-200.
[7] Warden C, Brantley MA Jr. Glycine-conjugated bile acids protect RPE tight junctions against oxidative stress and inhibit choroidal endothelial cell angiogenesis in vitro[J]. Biomolecules, 2021, 11(5):626.
[8] Shiha MG, Ashgar Z, Fraser EM, et al. High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome Ⅲ and Rome Ⅳ criteria[J]. EClinicalMedicine, 2020, 25:100465.
[9] Thibaut MM, Gillard J, Dolly A, et al. Bile acid dysregulation is intrinsically related to cachexia in tumor-bearing mice[J]. Cancers (Basel), 2021, 13(24):6389.
[10] Wahlstr?m A, Sayin SI, Marschall HU, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism[J]. Cell Metab, 2016, 24(1):41-50.
[11] Larabi AB, Masson HLP, B?umler AJ. Bile acids as modulators of gut microbiota composition and function[J]. Gut Microbes, 2023, 15(1):2172671.
[12] Ferrell JM, Pathak P, Boehme S, et al. Deficiency of both farnesoid X receptor and takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice[J]. Hepatology, 2019, 70(3):955-970.
[13] Jones BV, Begley M, Hill C, et al. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome[J]. Proc Natl Acad Sci U S A, 2008, 105(36):13580-13585.
[14] Song Z, Cai Y, Lao X, et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome[J]. Microbiome, 2019, 7(1):9.
[15] Funabashi M, Grove TL, Wang M, et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome[J]. Nature, 2020, 582(7813):566-570.
[16] Zheng X, Chen T, Jiang R, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism[J]. Cell Metab, 2021, 33(4):791-803.
[17] Doden HL, Wolf PG, Gaskins HR, et al. Completion of the gut microbial epi-bile acid pathway[J]. Gut Microbes, 2021, 13(1):1-20.
[18] Doden HL, Ridlon JM. Microbial hydroxysteroid dehydrogenases[J]. Microorganisms, 2021, 9(3):469.
[19] Hertel J, Harms AC, Heinken A, et al. Integrated analyses of microbiome and longitudinal metabolome data reveal microbial-host interactions on sulfur metabolism in Parkinson’s disease[J]. Cell Rep, 2019, 29(7):1767-1777.
[20] Alnouti Y. Bile acid sulfation: a pathway of bile acid elimination and detoxification[J]. Toxicol Sci, 2009, 108(2):225-246.
[21] Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids[J]. J Lipid Res, 2015, 56(6):1085-1099.
[22] Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis[J]. Cell Host Microbe, 2022, 30(3):289-300.
[23] Collins SL, Stine JG, Bisanz JE, et al. Bile acids and the gut microbiota: metabolic interactions and impacts on disease[J]. Nat Rev Microbiol, 2023, 21(4):236-247.
[24] Sato Y, Atarashi K, Plichta DR, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians[J]. Nature, 2021, 599(7885):458-464.
[25] Friedman E S, Li Y, Shen T-C D, et al. FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid[J]. Gastroenterology, 2018, 155(6): 1741-1752.
[26] He Z, Ma Y, Yang S, et al. Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase-producing enteroaggregative Escherichia coli infection[J]. Microbiome, 2022, 10(1): 79.
[27] Zhang S, Tun HM, Zhang D, et al. Alleviation of hepatic steatosis: dithizone-related gut microbiome restoration during Paneth cell dysfunction[J]. Front Microbiol, 2022, 13:813783.
[28] Zhou D, Wang Q, Liu H. Coronavirus disease 2019 and the gut-lung axis[J]. Int J Infect Dis, 2021, 113:300-307.
[29] Long X, Mu S, Zhang J, et al. GLOBAL signatures of the microbiome and metabolome during hospitalization of septic patients[J]. Shock, 2023, 59(5):716-724.
[30] Sun S, Wang D, Dong D, et al. Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis[J]. Crit Care, 2023, 27(1):127.
[31] Popli S, Badgujar PC, Agarwal T, et al. Persistent organic pollutants in foods, their interplay with gut microbiota and resultant toxicity[J]. Sci Total Environ, 2022, 832:155084.
[32] Monaghan T, Mullish BH, Patterson J, et al. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway[J]. Gut Microbes, 2019, 10(2):142-148.
[33] Monaghan TM, Duggal NA, Rosati E, et al. A multi-factorial observational study on sequential fecal microbiota transplant in patients with medically refractory clostridioides difficile infection[J]. Cells, 2021, 10(11):3234.
[34] Usui Y, Ayibieke A, Kamiichi Y, et al. Impact of deoxycholate on Clostridioides difficile growth, toxin production, and sporulation[J]. Heliyon, 2020, 6(4):e03717.
[35] Dubois T, Tremblay YDN, Hamiot A, et al. A microbiota-generated bile salt induces biofilm formation in Clostridium difficile[J]. NPJ Biofilms Microbiomes, 2019, 5(1):14.
[36] Papazyan R, Ferdyan N, Srinivasan K, et al. Human fecal bile acid analysis after investigational microbiota-based live biotherapeutic delivery for recurrent clostridioides difficile infection[J]. Microorganisms, 2023, 11(1):135.
[37] Liu H, Kohmoto O, Sakaguchi A, et al. Taurocholic acid, a primary 12α-hydroxylated bile acid, induces leakiness in the distal small intestine in rats[J]. Food Chem Toxicol, 2022, 165:113136.
[38] Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer[J]. Gut Microbes, 2016, 7(3):201-215.
[39] Horvatits T, Drolz A, Rutter K, et al. Circulating bile acids predict outcome in critically ill patients[J]. Ann Intensive Care, 2017, 7(1):48.
[40] Robinson JI, Weir WH, Crowley JR, et al. Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections[J]. J Clin Invest, 2019, 129(9):3792-3806.
[41] Mullish BH, McDonald JAK, Pechlivanis A, et al. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection[J]. Gut, 2019, 68(10):1791-1800.
[42] Alavi S, Mitchell JD, Cho JY, et al. Interpersonal gut microbiome variation drives susceptibility and resistance to cholera infection[J]. Cell, 2020, 181(7):1533-1546.
[43] Paramsothy S, Nielsen S, Kamm MA, et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis[J]. Gastroenterology, 2019, 156(5):1440-1454.
[44] Lou X, Xue J, Shao R, et al. Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances[J]. Front Immunol, 2023, 13:1063543.
[45] Kazemian N, Ramezankhani M, Sehgal A, et al. The trans-kingdom battle between donor and recipient gut microbiome influences fecal microbiota transplantation outcome[J]. Sci Rep, 2020, 10(1):18349.
[46] Buffie CG, Bucci V, Stein RR, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile[J]. Nature, 2015, 517(7533):205-208.
[47] Zhou C, Wang Y, Li C, et al. Amelioration of colitis by a gut bacterial consortium producing anti-inflammatory secondary bile acids[J]. Microbiol Spectr, 2023, 11(2):e0333022.
[48] Rao SC, Athalye-Jape GK, Deshpande GC, et al. Probiotic supplementation and late-onset sepsis in preterm infants[J]. Pediatrics, 2016, 137(3):e20153684.
[49] Chen L, Li H, Chen Y, et al. Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles[J]. Nutrition, 2020, 78:110863.
[50] Haring E, Uhl FM, Andrieux G, et al. Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect[J]. Haematologica, 2021, 106(8):2131-2146.
[51] Brevini T, Maes M, Webb GJ, et al. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2[J]. Nature, 2023, 615(7950):134-142.
[52] Gupta S, Arora A, Saini V, et al. Hydrophobicity of cholic acid-derived amphiphiles dictates the antimicrobial specificity[J]. ACS Biomater Sci Eng, 2022, 8(11):4996-5007.
Options
Outlines

/

〈 〉